Resolvin E1 – 25 µg

Brand:
Cayman
CAS:
552830-51-0
Storage:
-80
UN-No:
De Minimis - 1170 / 3

Resolvin E1 (RvE1) is a trihydroxy eicosapentaenoic acid (EPA; Item No. 90110) metabolite that has been identified in mouse inflammatory exudates and in human plasma when subjects are treated with both aspirin (Item No. 70260) and supplemental EPA.{21162,11433,13210} RvE1 is an anti-inflammatory EPA metabolite that has been shown to promote inflammatory resolution in numerous disease models, including experimental colitis, asthma, atherosclerosis, type 2 diabetes, and HSV-1-induced stromal keratitis.{14504,13209,15876,30594,30592,30593,30595,30596}  

 

Available on backorder

SKU: 10007848 - 25 µg Category:

Description

An anti-inflammatory EPA metabolite; identified in mouse inflammatory exudates and in human plasma when subjects are treated with both aspirin and supplemental EPA; promotes inflammatory resolution in numerous disease models, including experimental colitis, asthma, atherosclerosis, type 2 diabetes, and HSV-1-induced stromal keratitis,


Formal name: 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid

Synonyms:  RvE1

Molecular weight: 350.5

CAS: 552830-51-0

Purity: ≥95%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Lipoxins/Resolvin Es||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Specialized Pro-Resolving Mediators||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Lipoxygenase Pathways||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease